Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Colorectal Neoplasms 224Rectal Neoplasms 124Colonic Neoplasms 120Stomach Neoplasms 60Pancreatic Neoplasms 58Neoplasm Metastasis 48Lymphoma 39Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia 32Esophageal Neoplasms 32Neoplasms 31Burkitt Lymphoma 19Adenocarcinoma Of Esophagus 17Adenocarcinoma 17Carcinoma, Hepatocellular 13Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Unspecified Adult Solid Tumor, Protocol Specific 11Biliary Tract Neoplasms 11Lymphoma, Mantle-Cell 10Gallbladder Neoplasms 10Liver Neoplasms 9Osteosarcoma 8Lymphoma, Large-Cell, Immunoblastic 8Gastrointestinal Neoplasms 8Bile Duct Neoplasms 8Lymphoma, Follicular 7Dendritic Cell Sarcoma, Interdigitating 7Cholangiocarcinoma 7Leukemia, Myeloid, Acute 6

Interventions

Gemcitabine 8130-nm albumin-bound paclitaxel 5Albumin-Bound Paclitaxel 4napabucasin 2Oxaliplatin 2MK-4721 2Leucovorin 2Fluorouracil 2Carboplatin 2tremelimumab 1irinotecan sucrosofate 1ensituximab 1durvalumab 1contrast agent BR1 1cc-486 1Taxes 1Practice Guidelines as Topic 1Pancreaticoduodenectomy 1Paclitaxel 1PEGPH20 1Lead 1Irinotecan 1Enoxaparin 1EC regimen 1Drug Therapy 1Dexamethasone 1Cisplatin 1CP protocol 1Azacitidine 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Pancreatic Ductal × Leucovorin × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡